ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Hawaii Gets CBCCP Award

August 12, 1977

ASTRO Names Officers; Lane Returns To Rice Univ.

January 5, 2001

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004

NCI Stands Firm On Assist “Downscaling” Despite 150 Letters From States, Volunteers

January 15, 1993

Fruit, Candy Flavored Cigarettes Banned In U.S.; FDA To Examine Menthol Flavored Tobacco

September 25, 2009

NCI programs: AIDS Malignancy Program gets new director, authority.

November 4, 2005